JPMorgan Chase & Co. assumed coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a research note published on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $24.00 price objective on the stock. IMNM has been the subject of several other reports. Guggenheim initiated coverage on Immunome in a report on […]
Shares of Immunome, Inc. (NASDAQ:IMNM – Get Free Report) were up 2.7% on Tuesday . The company traded as high as $24.50 and last traded at $24.08. Approximately 59,193 shares traded hands during trading, a decline of 90% from the average daily volume of 570,022 shares. The stock had previously closed at $23.45. Analysts Set […]
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Investment analysts at Wedbush issued their Q1 2024 earnings per share (EPS) estimates for Immunome in a research note issued on Tuesday, February 6th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.24) per share for the quarter. Wedbush currently has a “Outperform” rating […]
Leerink Partnrs restated their outperform rating on shares of Immunome (NASDAQ:IMNM – Free Report) in a research report released on Monday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for Immunome’s Q4 2023 earnings at ($0.25) EPS, FY2023 earnings at ($0.50) EPS, Q1 2024 earnings at ($1.05) EPS, Q2 2024 earnings at ($0.12) EPS, Q3 […]
Dorsey Wright & Associates purchased a new position in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The firm purchased 3,100 shares of the company’s stock, valued at approximately $26,000. Several other large investors also recently modified their holdings of IMNM. Natixis bought a new position in Immunome in […]